Stephen Wolverton

  • 305 Citations
  • 10 h-Index
1985 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

2019

Pyoderma gangrenosum: A presenting sign of myelodysplastic syndrome in undiagnosed fanconi anemia

Kandula, P., Shah, K. M., Wolverton, J. E., Le, C. & Wolverton, S., Jan 1 2019, In : Dermatology Online Journal. 25, 1

Research output: Contribution to journalArticle

1 Scopus citations
2017

Traditional immune-modulating drugs

Wolverton, S. & Aouthmany, M., Apr 24 2017, Clinical and Basic Immunodermatology: Second Edition. Springer International Publishing, p. 803-814 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2016

Medical Malpractice in Dermatology—Part I: Reducing the Risks of a Lawsuit

Shah, V. V., Kapp, M. B. & Wolverton, S., Dec 1 2016, In : American Journal of Clinical Dermatology. 17, 6, p. 593-600 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Medical Malpractice in Dermatology—Part II:  What To Do Once You Have Been Served with a Lawsuit

Shah, V. V., Kapp, M. B. & Wolverton, S., Dec 1 2016, In : American Journal of Clinical Dermatology. 17, 6, p. 601-607 7 p.

Research output: Contribution to journalArticle

Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate

Veerula, V. L., Ezra, N., Aouthmany, M., Graham, T. A., Wolverton, S. & Somani, A-K., 2016, In : Cutis. 98, 6, p. E12-E15

Research output: Contribution to journalArticle

3 Scopus citations

Practice Gaps: Drug Reactions

Wolverton, S., Jul 1 2016, In : Dermatologic Clinics. 34, 3, p. 311-318 8 p.

Research output: Contribution to journalReview article

1 Scopus citations
2014

Drug hypersensitivity syndrome in a patient receiving vismodegib

Lam, T., Wolverton, S. E. & Davis, C. L., Mar 2014, In : Journal of the American Academy of Dermatology. 70, 3, p. e65-e66

Research output: Contribution to journalArticle

8 Scopus citations

Drug-Induced Acneiform Eruptions: Drug-induced Acneiform Eruptions

Do, H. K., Ezra, N. & Wolverton, S. E., Jan 1 2014, Acneiform Eruptions in Dermatology: A Differential Diagnosis. Springer New York, p. 389-404 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2013

Important controversies associated with isotretinoin therapy for acne

Wolverton, S. E. & Harper, J. C., Apr 1 2013, In : American Journal of Clinical Dermatology. 14, 2, p. 71-76 6 p.

Research output: Contribution to journalReview article

25 Scopus citations

Top-accessed article: Topical rapamycin

Haggstrom, A. N. & Wolverton, S. E., Feb 1 2013, In : JAMA Dermatology. 149, 2, 1 p.

Research output: Contribution to journalComment/debate

2011

Immunosuppression and sebaceous tumors: A confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy

Landis, M. N., Davis, C. L., Bellus, G. A. & Wolverton, S. E., Nov 2011, In : Journal of the American Academy of Dermatology. 65, 5, p. 1054-1058.e1

Research output: Contribution to journalReview article

24 Scopus citations
2010

Recent trends in systemic psoriasis treatment costs

Beyer, V. & Wolverton, S. E., Jan 1 2010, In : Archives of Dermatology. 146, 1, p. 46-54 9 p.

Research output: Contribution to journalArticle

67 Scopus citations
2009

Can short courses of systemic corticosteroids truly cause osteonecrosis?

Wolverton, S. E., Sep 1 2009, In : Dermatologic Therapy. 22, 5, p. 458-464 7 p.

Research output: Contribution to journalReview article

4 Scopus citations

Introduction: Controversies in dermatologic drug therapy

Wolverton, S. E., Sep 1 2009, In : Dermatologic Therapy. 22, 5, 1 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis

Weaver, C. H., Huddleston, H. M., Kingsley, M. M. & Wolverton, S. E., Nov 1 2009, In : Journal of Drugs in Dermatology. 8, 11, p. 1031-1033 3 p.

Research output: Contribution to journalArticle

8 Scopus citations

Optimizing clinical use of azathioprine with newer pharmacogenetic data

Wolverton, S. E., Jun 1 2009, In : Archives of Dermatology. 145, 6, p. 707-710 4 p.

Research output: Contribution to journalEditorial

4 Scopus citations
2008

Traditional immune-modulating drugs

Wolverton, S. E., Dec 1 2008, Clinical and Basic Immunodermatology. Springer London, p. 551-559 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2007

Suggested Guidelines for Patient Monitoring: Hepatic and Hematologic Toxicity Attributable to Systemic Dermatologic Drugs

Wolverton, S. E. & Remlinger, K., Apr 1 2007, In : Dermatologic Clinics. 25, 2, p. 195-205 11 p.

Research output: Contribution to journalReview article

21 Scopus citations

The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.

Allen, K. J. & Wolverton, S. E., Sep 2007, In : Journal of drugs in dermatology : JDD. 6, 9, p. 883-889 7 p.

Research output: Contribution to journalReview article

21 Scopus citations
2006

Pemphigus foliaceus with epidermal detachment: Adverse events from patch testing

Cocklin, C. L., Shackelford, K., Wolverton, S. E. & Fett, D. D., Mar 1 2006, In : Dermatitis. 17, 1, p. 32-35 4 p.

Research output: Contribution to journalArticle

1 Scopus citations
1997

The Muir-Torre syndrome in a black patient with AIDS: Histopathology and molecular genetic studies

Warschau, K. E., Eble, J. N., Hood, A. F., Wolverton, S. E. & Halling, K. C., 1997, In : Journal of Cutaneous Pathology. 24, 8, p. 511-518 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Update on cutaneous drug reactions.

Wolverton, S. E., 1997, In : Advances in dermatology. 13, p. 65-84 20 p.

Research output: Contribution to journalReview article

11 Scopus citations
1996

Dermatologic drug formulary: An American Academy of Dermatology white paper

Steger, J. W., Wolverton, S. E., Greenberg, R. D., Ling, M. R., Resnick, S. D. & James, W. D., Jan 1996, In : Journal of the American Academy of Dermatology. 34, 1, p. 99-109 11 p.

Research output: Contribution to journalArticle

7 Scopus citations
1995

Major adverse effects from systemic drugs: Defining the risks

Wolverton, S., 1995, In : Current Problems in Dermatology (United States). 7, 1, p. 6-38 33 p.

Research output: Contribution to journalArticle

10 Scopus citations
1992

Monitoring for adverse effects from systemic drugs used in dermatology

Wolverton, S. E., Jan 1 1992, In : Journal of the American Academy of Dermatology. 26, 5, p. 661-679 19 p.

Research output: Contribution to journalArticle

25 Scopus citations
1991

Systemic Drug Therapy for Psoriasis: The Most Critical Issues

Wolverton, S. E., Apr 1991, In : Archives of Dermatology. 127, 4, p. 565-568 4 p.

Research output: Contribution to journalArticle

6 Scopus citations
1985

A survey of resident perceptions of effective teaching behaviors.

Wolverton, S. E. & Bosworth, M. F., May 1 1985, In : Family medicine. 17, 3, p. 106-108 3 p.

Research output: Contribution to journalArticle

35 Scopus citations